EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cooperative induction of CXCL chemokines by inflammatory cytokines and oxidized phospholipids

Alma Hodzic, Bernd Gesslbauer iD, Valery Bochkov iD, Olga V Oskolkova iD

Immunology · 2024

DOI: 10.1111/imm.13773 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology, 2024. Verfasst von Alma Hodzic und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Graz, Graz, Austria. Hauptthemen laut MEDLINE: Phosphatidylcholines, Tumor Necrosis Factor-alpha, Interleukin-1beta. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EU-Cost, Austrian Science Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation is initiated and driven by a mixture of mediators, which modify effects of each other. This study analysed in vitro pro‐inflammatory activity of inflammatory cytokines (TNFα and IL‐1β) in a combination with a lipid DAMP molecule, oxidized palmitoyl‐arachidonoyl‐phosphatidylcholine (OxPAPC). The study was performed on endothelial and monocytic cell lines. The cells were treated with different concentrations of TNFα or IL‐1β, OxPAPC and their combinations, either in the presence or absence of drugs regulating inflammation. Pro‐inflammatory effects of TNFα/IL‐1β and OxPAPC were estimated by analysis of chemokines CXCL8, CXCL2 and CXCL3 by ELISA and RT‐PCR. Toxicity was determined by analysis of metabolic activity. Statistical significance was estimated by ANOVA and Dunnett's test. OxPAPC was a much weaker chemokine inducer as compared to TNFα or IL‐1β. However, OxPAPC and TNFα/IL‐1β together induced effects that were significantly stronger than the arithmetical sum of individual effects. This cooperative action of OxPAPC and TNFα was reversed by inhibitors of p38 MAPK. We hypothesise that the boosting of TNFα and IL‐1β effects by OxPAPC may be more pathologically important than the action of the lipid alone. Inhibitors of p38 MAPK may become a tool for analysis of pathological role of oxidized phospholipids.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhosphatidylcholinesTumor Necrosis Factor-alphaInterleukin-1betaHumansOxidation-Reductionp38 Mitogen-Activated Protein KinasesInflammation MediatorsInflammationChemokines, CXCCytokinesCell LinePhospholipidsMonocytes

Stichwörter der Autor:innen

chemokinescytokinesendothelial cellsinflammation

Substanzen

PhosphatidylcholinesTumor Necrosis Factor-alphaInterleukin-1betaoxidized-L-alpha-1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphorylcholinep38 Mitogen-Activated Protein KinasesInflammation MediatorsChemokines, CXCCytokinesPhospholipids

Autor:innen und Institutionen

  • Institute of Pharmaceutical Sciences, Department of Pharmaceutical Chemistry, University of Graz, Graz, Austria.
  • Field of Excellence BioHealth, University of Graz, Graz, Austria.

ORCID-Profile: Bernd Gesslbauer, Valery Bochkov, Olga V Oskolkova

Förderung

  • EU-Cost
  • Austrian Science Fund

Zitieren

APA

Hodzic, A., Gesslbauer, B., Bochkov, V., & Oskolkova, O. V. (2024). Cooperative induction of CXCL chemokines by inflammatory cytokines and oxidized phospholipids. Immunology. https://doi.org/10.1111/imm.13773

Vancouver

Hodzic A, Gesslbauer B, Bochkov V, Oskolkova OV. Cooperative induction of CXCL chemokines by inflammatory cytokines and oxidized phospholipids. Immunology. 2024. doi:10.1111/imm.13773

BibTeX
@article{Hodzic2024,
  author = {Hodzic, Alma and Gesslbauer, Bernd and Bochkov, Valery and Oskolkova, Olga V},
  title = {Cooperative induction of CXCL chemokines by inflammatory cytokines and oxidized phospholipids},
  journal = {Immunology},
  year = {2024},
  doi = {10.1111/imm.13773}
}
Kostenlos starten →